Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5286408, 6 pages
https://doi.org/10.1155/2017/5286408
Research Article

Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes

1Department of Internal Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China
2Department of Medical Ultrasound, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China

Correspondence should be addressed to Dao Wen Wang; nc.ude.umjt.hjt@gnawwd

Received 19 July 2017; Accepted 24 September 2017; Published 10 December 2017

Academic Editor: Lance A. Liotta

Copyright © 2017 Lei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Enroth, A. Johansson, S. B. Enroth, and U. Gyllensten, “Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs,” Nature Communications, vol. 5, p. 4684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Prensner, M. A. Rubin, J. T. Wei, and A. M. Chinnaiyan, “Beyond PSA: the next generation of prostate cancer biomarkers,” Science Translational Medicine, vol. 4, no. 127, article 127rv3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Reiser, R. Klingenberg, D. Hof et al., “Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 8, pp. 1872–1879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants,” The Lancet, vol. 378, no. 9785, pp. 31–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. W. H. Herman, W. Ye, S. J. Griffin et al., “Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe),” Diabetes Care, vol. 38, no. 8, pp. 1449–1455, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Menke, S. Casagrande, L. Geiss, and C. C. Cowie, “Prevalence of and trends in diabetes among adults in the United States, 1988–2012,” JAMA, vol. 314, no. 10, pp. 1021–1029, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Nowak, J. Sundström, S. Gustafsson et al., “Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts,” Diabetes, vol. 65, no. 1, pp. db150881–db150884, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Langley, K. Willeit, A. Didangelos et al., “Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques,” The Journal of Clinical Investigation, vol. 127, no. 4, pp. 1546–1560, 2017. View at Publisher · View at Google Scholar
  9. S. Reddy, A. Amutha, R. Rajalakshmi et al., “Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy,” Journal of Diabetes and its Complications, vol. 31, no. 5, pp. 804–809, 2017. View at Publisher · View at Google Scholar
  10. P. Benes, V. Vetvicka, and M. Fusek, “Cathepsin D—many functions of one aspartic protease,” Critical Reviews in Oncology/Hematology, vol. 68, no. 1, pp. 12–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Haidar, R. S. Kiss, L. Sarov-Blat et al., “Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux,” Journal of Biological Chemistry, vol. 281, no. 52, pp. 39971–39981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Moallem, F. Nazemian, S. Eliasi, S. A. Alamdaran, J. Shamsara, and A. H. Mohammadpour, “Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients,” International Urology and Nephrology, vol. 43, no. 3, pp. 841–848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. M. A. Walenbergh, T. Houben, S. S. Rensen et al., “Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention,” Scientific Reports, vol. 6, no. 1, article 38278, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Snir, M. Suchy, K. S. Lawrence, R. H. E. Hudson, S. H. Pasternak, and R. Bartha, “Prolonged in vivo retention of a cathepsin D targeted optical contrast agent in a mouse model of Alzheimer’s disease,” Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 73–87, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Bae, N. Y. Yang, C. Lee, S. Kim, H. J. Lee, and S. J. Lee, “Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates,” Cell Death and Disease, vol. 6, no. 10, article e1901, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. H. Yamac, E. Sevgili, S. Kucukbuzcu et al., “Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI,” Herz, vol. 40, no. 6, pp. 912–920, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. American Diabetes Association, “Standards of medical care in diabetes—2014,” Diabetes Care, vol. 37, Supplement 1, no. Supplement_1, pp. S14–S80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Tei, K. S. Dujardin, D. O. Hodge, R. A. Kyle, A. Jamil Tajik, and J. B. Seward, “Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidisis,” Journal of the American College of Cardiology, vol. 28, no. 3, pp. 658–664, 1996. View at Publisher · View at Google Scholar
  19. M. Maynadier, R. Farnoud, P. J. Lamy, V. Laurent-Matha, M. Garcia, and H. Rochefort, “Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment,” International Journal of Oncology, vol. 43, no. 5, pp. 1683–1690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Gemoll, F. Epping, L. Heinrich et al., “Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies,” Oncotarget, vol. 6, no. 18, pp. 16517–16526, 2015. View at Publisher · View at Google Scholar
  21. O. Masson, A.-S. Bach, D. Derocq et al., “Pathophysiological functions of cathepsin D: targeting its catalytic activity versus its protein binding activity?” Biochimie, vol. 92, no. 11, pp. 1635–1643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kanamori, G. Takemura, K. Goto et al., “The role of autophagy emerging in postinfarction cardiac remodelling,” Cardiovascular Research, vol. 91, no. 2, pp. 330–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Fernandez-Montoya and M. Perez, “Cathepsin D in a murine model of frontotemporal dementia with Parkinsonism-linked to chromosome 17,” Journal of Alzheimer's Disease, vol. 45, no. 1, pp. 1–14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. E. J. Chang, S. K. Lee, Y. S. Song et al., “IL-34 is associated with obesity, chronic inflammation, and insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 7, pp. E1263–E1271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Eguchi and A. E. Feldstein, “Lysosomal cathepsin D contributes to cell death during adipocyte hypertrophy,” Adipocyte, vol. 2, no. 3, pp. 170–175, 2013. View at Publisher · View at Google Scholar
  26. S. Grimm, M. Horlacher, B. Catalgol, A. Hoehn, T. Reinheckel, and T. Grune, “Cathepsins D and L reduce the toxicity of advanced glycation end products,” Free Radical Biology & Medicine, vol. 52, no. 6, pp. 1011–1023, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Ozkayar, S. Piskinpasa, F. Akyel et al., “Relation between serum cathepsin D levels and endothelial dysfunction in patients with chronic kidney disease,” Nefrología, vol. 35, no. 1, pp. 72–79, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Y. Kim, M. Lee, H. W. Kang, and C. S. Moon, “Cathepsin D levels are reduced in patients with preeclampsia in Korean population,” Clinical Biochemistry, vol. 46, no. 18, pp. 1808–1811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Zhong, A. F. Chen, J. Zhao, Y. J. Gu, and G. X. Fu, “Serum levels of cathepsin D, sirtuin1, and endothelial nitric oxide synthase are correlatively reduced in elderly healthy people,” Aging Clinical and Experimental Research, vol. 28, no. 4, pp. 641–645, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Samie and H. Xu, “Lysosomal exocytosis and lipid storage disorders,” Journal of Lipid Research, vol. 55, no. 6, pp. 995–1009, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Gonçalves, K. Hultman, P. Dunér et al., “High levels of cathepsin D and cystatin B are associated with increased risk of coronary events,” Open Heart, vol. 3, no. 1, article e000353, 2016. View at Publisher · View at Google Scholar
  32. D. Liu, K. Hu, S. Herrmann et al., “Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis,” The International Journal of Cardiovascular Imaging, vol. 33, no. 6, pp. 837–845, 2017. View at Publisher · View at Google Scholar
  33. J. Arnlov, E. Ingelsson, U. Riserus, B. Andren, and L. Lind, “Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men,” European Heart Journal, vol. 25, no. 24, pp. 2220–2225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. M. M. Al-Daydamony, M. A. El-Tahlawi, and A. Shawky, “Can myocardial performance index predict the presence of silent ischemia in asymptomatic type 2 diabetic patients?” Echocardiography, vol. 33, no. 12, pp. 1823–1827, 2016. View at Publisher · View at Google Scholar · View at Scopus